Publications by authors named "Mariette Labots"

Claim this Profile
A
Acceptance in Patients With Cancer: A Scoping Review.
Joost Dekker, Chris Welling, Mariette Labots

Cancer Rep (Hoboken)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early [18F]FDG PET/CT response after a single dose of anti-EGFR therapy as a predictive biomarker for treatment benefit in patients with advanced colorectal cancer.
Sophie Louise Gerritse, Erik J van Helden, Anne I J Arens, Ronald Boellaard, Tineke E Buffart, Mariette Labots

Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SUNRISE-CRC: a randomized phase II study of high-dose intermittent sunitinib versus trifluridine/tipiracil in metastatic colorectal carcinoma.
Jorien B E Janssen, Kirti K Iyer, Sophie L Gerritse, Eline Janssen, Elske C Gootjes, Mariette Labots

Oncologist· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indicators of maladaptive emotions in patients with cancer as assessed by oncologists and nurses.
G Elise Doppenberg-Smit, Myra E van Linde, Femke Lamers, Adriaan W Hoogendoorn, Annemarie M J Braamse, Mariette Labots

Support Care Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets.
Jaco C Knol, Mengge Lyu, Franziska Böttger, Madalena Nunes Monteiro, Thang V Pham, Mariette Labots

Cancer Cell· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Cholecystitis as the first manifestation of metastatic melanoma].
Sam Wijers, Bas Polle, Johan Janssen, Babs Zonderhuis, Mariette Labots

Ned Tijdschr Geneeskd· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KRAS mutation status integrated with RNA subtyping improves prognostic modeling in FOLFIRINOX-treated metastatic pancreatic cancer.
Marjolein F Lansbergen, Mark P G Dings, Jan Koster, Mariette Labots, Emile D Kerver

Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort study.
Mark Schuiveling, Laurens S Ter Maat, Isabella A J Van Duin, Rik J Verheijden, Max F Troenokarso, Mariette Labots

J Natl Cancer Inst· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monocyte-related markers as predictors of immune checkpoint inhibitor efficacy and immune-related adverse events: a systematic review and meta-analysis.
Aiarpi Ezdoglian, Michel Tsang-A-Sjoe, Fatemeh Khodadust, George Burchell, Gerrit Jansen, Mariette Labots

Cancer Metastasis Rev· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Innate Immune Landscape of dMMR/MSI Cancers Predicts the Outcome of Nivolumab Treatment: Results from the Drug Rediscovery Protocol.
Laurien J Zeverijn, Birgit S Geurts, Thomas W Battaglia, Jade M van Berge Henegouwen, Gijs F de Wit, Mariette Labots

Clin Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline tumor-infiltrating lymphocyte patterns and response to immune checkpoint inhibition in metastatic cutaneous melanoma.
Isabella A J van Duin, Mark Schuiveling, Laurens S Ter Maat, Wouter A C van Amsterdam, Franchette van den Berkmortel, Mariette Labots

Eur J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma.
Rik J Verheijden, Femke H Burgers, Josephine C Janssen, Anouk E Putker, Sophie P G R Veenstra, Mariette Labots

Eur J Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of discordance between mismatch repair deficiency and microsatellite instability testing may prevent inappropriate treatment with immunotherapy.
Birgit S Geurts, Laurien J Zeverijn, Jade M van Berge Henegouwen, Hanneke van der Wijngaart, Louisa R Hoes, Mariette Labots

J Pathol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The STELLAR trial: a phase II/III randomized trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma.
Jorien B E Janssen, Cyrillo G Brahm, Chantal M L Driessen, Janine Nuver, Mariette Labots

Brain Commun· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma.
Lindsay V M Leek, Jessica C L Notohardjo, Karlijn de Joode, Eline L Velker, John B A G Haanen, Mariette Labots

Sci Rep· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access Protocol.
Karlijn Verkerk, Birgit S Geurts, Laurien J Zeverijn, Vincent van der Noort, Henk M W Verheul, Mariette Labots

Lancet Reg Health Eur· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing renal function assessment prior to platinum-based chemotherapy: a real-world evaluation.
Suzanne Van der Gaag, Mariette Labots, Eleonora L Swart, Mirjam Crul

Acta Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of measuring body weight in (sub)populations of patients with cancer treated with chemotherapy.
Shirley Kemps, Mostafa Soleyman, Harmen Huls, Mariette Labots, Mirjam Crul

Eur J Hosp Pharm· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Rheumatic adverse events due to immune checkpoint inhibitors].
Wouter H van Binsbergen, Sjoerd C Heslinga, Willem F Lems, Michel W P Tsang-A-Sjoe, Mariette Labots

Ned Tijdschr Geneeskd· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Candidate biomarkers for treatment benefit from sunitinib in patients with advanced renal cell carcinoma using mass spectrometry-based (phospho)proteomics.
Hanneke van der Wijngaart, Robin Beekhof, Jaco C Knol, Alex A Henneman, Richard de Goeij-de Haas, Mariette Labots

Clin Proteomics· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphoproteomics of patient-derived xenografts identifies targets and markers associated with sensitivity and resistance to EGFR blockade in colorectal cancer.
Robin Beekhof, Andrea Bertotti, Franziska Böttger, Valentina Vurchio, Francesca Cottino, Mariette Labots

Sci Transl Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing wide implementation of precision oncology: A liquid nitrogen-free snap freezer preserves molecular profiles of biological samples.
Hanneke van der Wijngaart, Sahil Jagga, Henk Dekker, Richard de Goeij, Sander R Piersma, Mariette Labots

Cancer Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying somatic changes in drug transporters using whole genome and transcriptome sequencing data of advanced tumors.
Wesley S van de Geer, Ron H J Mathijssen, Job van Riet, Neeltje Steeghs, Mariette Labots

Biomed Pharmacother· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours.
Birgit S Geurts, Thomas W Battaglia, J Maxime van Berge Henegouwen, Laurien J Zeverijn, Gijs F de Wit, Mariette Labots

BMC Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dose Intermittent Treatment with the Multikinase Inhibitor Sunitinib Leads to High Intra-Tumor Drug Exposure in Patients with Advanced Solid Tumors.
Sophie L Gerritse, Mariette Labots, Rob Ter Heine, Henk Dekker, Dennis Poel

Cancers (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis